Spatial Patterns of White Matter Hyperintensities Associated with Alzheimer's Disease Risk Factors in a Cognitively Healthy Middle-aged Cohort

Overview

Journal Alzheimers Res Ther

Date 2019 Jan 26

PMID 30678723

Citations 34

Authors

Gemma Salvado

Anna Brugulat-Serrat

Carole H Sudre

Oriol Grau-Rivera

Marc Suarez-Calvet

Carles Falcon

Karine Fauria

M Jorge Cardoso

Frederik Barkhof

Jose Luis Molinuevo

Juan Domingo Gispert

Affiliations

Soon will be listed here.

Abstract

Background: White matter hyperintensities (WMH) of presumed vascular origin have been associated with an increased risk of Alzheimer's disease (AD). This study aims to describe the patterns of WMH associated with dementia risk estimates and individual risk factors in a cohort of middle-aged/late middle-aged individuals (mean 58 (interquartile range 51-64) years old).

Methods: Magnetic resonance imaging and AD risk factors were collected from 575 cognitively unimpaired participants. WMH load was automatically calculated in each brain lobe and in four equidistant layers from the ventricular surface to the cortical interface. Global volumes and regional patterns of WMH load were analyzed as a function of the Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) dementia risk score, as well as family history of AD and Apolipoprotein E (APOE) genotype. Additional analyses were performed after correcting for the effect of age and hypertension.

Results: The studied cohort showed very low WMH burden (median 1.94 cm) and 20-year dementia risk estimates (median 1.47 %). Even so, higher CAIDE scores were significantly associated with increased global WMH load. The main drivers of this association were age and hypertension, with hypercholesterolemia and body mass index also displaying a minor, albeit significant, influence. Regionally, CAIDE scores were positively associated with WMH in anterior areas, mostly in the frontal lobe. Age and hypertension showed significant association with WMH in almost all regions analyzed. The APOE-ε2 allele showed a protective effect over global WMH with a pattern that comprised juxtacortical temporo-occipital and fronto-parietal deep white matter regions. Participants with maternal family history of AD had higher WMH load than those without, especially in temporal and occipital lobes.

Conclusions: WMH load is associated with AD risk factors even in cognitively unimpaired subjects with very low WMH burden and dementia risk estimates. Our results suggest that tight control of modifiable risk factors in middle-age/late middle-age could have a significant impact on late-life dementia.

Citing Articles

Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease.

Singh S, Singh R Mol Biol Rep. 2025; 52(1):173.

PMID: 39880979 DOI: 10.1007/s11033-025-10297-6.

Molecular profiling of frontal and occipital subcortical white matter hyperintensities in Alzheimer's disease.

Malla S, Bryant A, Jayakumar R, Woost B, Wolf N, Li A Front Neurol. 2025; 15():1470441.

PMID: 39845935 PMC: 11753232. DOI: 10.3389/fneur.2024.1470441.

Mediterranean diet and dementia: MRI marker evidence from meta-analysis.

Wang X, Xin Z, Li X, Wu K, Wang W, Guo L Eur J Med Res. 2025; 30(1):32.

PMID: 39815306 PMC: 11737277. DOI: 10.1186/s40001-025-02276-1.

Modifiable dementia risk associated with smaller white matter volume and altered 1/f aperiodic brain activity: cross-sectional insights from the LEISURE study.

Pace T, Levenstein J, Anijarv T, Campbell A, Treacy C, Hermens D Age Ageing. 2024; 53(11).

PMID: 39523601 PMC: 11551051. DOI: 10.1093/ageing/afae243.

Hypertension and cerebral blood flow in the development of Alzheimer's disease.

Bachmann D, Saake A, Studer S, Buchmann A, Rauen K, Gruber E Alzheimers Dement. 2024; 20(11):7729-7744.

PMID: 39254220 PMC: 11567827. DOI: 10.1002/alz.14233.

References

Jeerakathil T, Wolf P, Beiser A, Massaro J, Seshadri S, DAgostino R . Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004; 35(8):1857-61. DOI: 10.1161/01.STR.0000135226.53499.85. View

Hirono N, Yasuda M, Tanimukai S, Kitagaki H, Mori E . Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia. Stroke. 2000; 31(6):1263-8. DOI: 10.1161/01.str.31.6.1263. View

Ithapu V, Singh V, Lindner C, Austin B, Hinrichs C, Carlsson C . Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies. Hum Brain Mapp. 2014; 35(8):4219-35. PMC: 4107160. DOI: 10.1002/hbm.22472. View

Wardlaw J, Smith C, Dichgans M . Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013; 12(5):483-97. PMC: 3836247. DOI: 10.1016/S1474-4422(13)70060-7. View

Sawada H, Udaka F, Izumi Y, Nishinaka K, Kawakami H, Nakamura S . Cerebral white matter lesions are not associated with apoE genotype but with age and female sex in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000; 68(5):653-6. PMC: 1736920. DOI: 10.1136/jnnp.68.5.653. View

de Leeuw F, de Groot J, Achten E, Oudkerk M, Ramos L, Heijboer R . Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2000; 70(1):9-14. PMC: 1763449. DOI: 10.1136/jnnp.70.1.9. View

Sachdev P, Parslow R, Wen W, Anstey K, Easteal S . Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging. 2007; 30(6):946-56. DOI: 10.1016/j.neurobiolaging.2007.08.023. View

Ramier A, HECAEN H . [Respective rôles of frontal lesions and lesion lateralization in "verbal fluency" deficiencies]. Rev Neurol (Paris). 1970; 123(1):17-22. View

Pena-Casanova J, Quinones-Ubeda S, Gramunt-Fombuena N, Quintana-Aparicio M, Aguilar M, Badenes D . Spanish Multicenter Normative Studies (NEURONORMA Project): norms for verbal fluency tests. Arch Clin Neuropsychol. 2009; 24(4):395-411. DOI: 10.1093/arclin/acp042. View

10.

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H . Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016; 15(5):455-532. DOI: 10.1016/S1474-4422(16)00062-4. View

11.

Buschke H, Kuslansky G, Katz M, Stewart W, Sliwinski M, Eckholdt H . Screening for dementia with the memory impairment screen. Neurology. 1999; 52(2):231-8. DOI: 10.1212/wnl.52.2.231. View

12.

Brickman A, Provenzano F, Muraskin J, Manly J, Blum S, Apa Z . Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol. 2012; 69(12):1621-7. PMC: 3597387. DOI: 10.1001/archneurol.2012.1527. View

13.

Lee S, Viqar F, Zimmerman M, Narkhede A, Tosto G, Benzinger T . White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016; 79(6):929-39. PMC: 4884146. DOI: 10.1002/ana.24647. View

14.

Stephen R, Liu Y, Ngandu T, Rinne J, Kemppainen N, Parkkola R . Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition. J Alzheimers Dis. 2017; 59(2):695-705. PMC: 5523839. DOI: 10.3233/JAD-170092. View

15.

Wiegman A, Meier I, Provenzano F, Schupf N, Manly J, Stern Y . Regional white matter hyperintensity volume and cognition predict death in a multiethnic community cohort of older adults. J Am Geriatr Soc. 2013; 61(12):2246-2248. PMC: 3874729. DOI: 10.1111/jgs.12568. View

16.

Ambrosius W, Sink K, Foy C, Berlowitz D, Cheung A, Cushman W . The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014; 11(5):532-46. PMC: 4156910. DOI: 10.1177/1740774514537404. View

17.

Habes M, Sotiras A, Erus G, Toledo J, Janowitz D, Wolk D . White matter lesions: Spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy. Neurology. 2018; 91(10):e964-e975. PMC: 6139818. DOI: 10.1212/WNL.0000000000006116. View

18.

Cacciaglia R, Molinuevo J, Falcon C, Brugulat-Serrat A, Sanchez-Benavides G, Gramunt N . Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease. Alzheimers Dement. 2018; 14(7):902-912. DOI: 10.1016/j.jalz.2018.01.016. View

19.

Lyall D, Munoz Maniega S, Harris S, Bastin M, Murray C, Lutz M . APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds. Int J Stroke. 2015; 10(8):1297-300. PMC: 4950052. DOI: 10.1111/ijs.12615. View

20.

Iturria-Medina Y, Sotero R, Toussaint P, Mateos-Perez J, Evans A . Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun. 2016; 7:11934. PMC: 4919512. DOI: 10.1038/ncomms11934. View